APA (7. basım) Alıntı

Lubaba, A., & Fariha, L. M. (2024). PCSK9i: Proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment. Brac University.

Chicago Style (17. basım) Atıf

Lubaba, Anikah, ve Luluel Maknun Fariha. PCSK9i: Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor a New Phase of Lipid-lowering Treatment. Brac University, 2024.

MLA (8th ed.) Atıf

Lubaba, Anikah, ve Luluel Maknun Fariha. PCSK9i: Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor a New Phase of Lipid-lowering Treatment. Brac University, 2024.